Form 4: CONMED Corp Director Exercises Stock Appreciation Rights and Disposes of Shares
SEC Form 4 Filing
Director Charles Farkas exercised stock appreciation rights and disposed of shares of CONMED Corp on September 5, 2024.
Summary
- On September 5, 2024, Charles Farkas, a director of CONMED Corp, exercised stock appreciation rights (SARs) converting them into 1,000 shares of common stock at a price of $39.64.
- Following the exercise, Farkas disposed of 534 shares of common stock at a price of $74.31.
- After these transactions, Farkas directly owns 20,346 shares of CONMED Corp.
- The SARs were granted under the company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, vesting on June 1, 2015, and expiring on September 11, 2024.
- Farkas has a power of attorney on file, executed on March 22, 2024, allowing designated individuals to handle SEC filings on his behalf.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.
Positives
- The exercise of SARs and subsequent disposal of shares indicates that the director is realizing value from the company's equity compensation plan.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, such as directors and officers, trade in their company's stock. These filings provide transparency to the market regarding insider activity.
Comparison to Industry Standards
- Monitoring Form 4 filings is a common practice in the financial industry to gauge insider sentiment.
- Comparing the trading activity of CONMED Corp insiders to those of similar medical device companies like Stryker (SYK) or Medtronic (MDT) can provide insights into the relative valuation and prospects of CONMED.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 2007 | Year of the Amended and Restated Non-Employee Director Equity Compensation Plan |
| 06/01/2015 | Vesting date of the Stock Appreciation Rights (SARs) |
| 03/22/2024 | Date of execution of the Limited Power of Attorney |
| 05/22/2024 | Date of acknowledgement of the Limited Power of Attorney |
| 09/05/2024 | Date of transaction (exercise of SARs and disposal of shares) |
| 09/09/2024 | Date of signature on the Form 4 |
| 09/11/2024 | Expiration date of the Stock Appreciation Rights (SARs) |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.